105 related articles for article (PubMed ID: 17912455)
21. Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.
Horvath Z; Marihart-Fazekas S; Saiko P; Grusch M; Ozsüy M; Harik M; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Djavan B; Szekeres T
Anticancer Res; 2007; 27(5A):3459-64. PubMed ID: 17970095
[TBL] [Abstract][Full Text] [Related]
22. Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
Raje N; Kumar S; Hideshima T; Ishitsuka K; Yasui H; Chhetri S; Vallet S; Vonescu E; Shiraishi N; Kiziltepe T; Elford HL; Munshi NC; Anderson KC
Br J Haematol; 2006 Oct; 135(1):52-61. PubMed ID: 16925573
[TBL] [Abstract][Full Text] [Related]
23. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
24. Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro.
Madlener S; Saiko P; Vonach C; Viola K; Huttary N; Stark N; Popescu R; Gridling M; Vo NT; Herbacek I; Davidovits A; Giessrigl B; Venkateswarlu S; Geleff S; Jäger W; Grusch M; Kerjaschki D; Mikulits W; Golakoti T; Fritzer-Szekeres M; Szekeres T; Krupitza G
Br J Cancer; 2010 Apr; 102(9):1361-70. PubMed ID: 20424615
[TBL] [Abstract][Full Text] [Related]
25. Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.
Fritzer-Szekeres M; Grusch M; Luxbacher C; Horvath S; Krupitza G; Elford HL; Szekeres T
Exp Hematol; 2000 Aug; 28(8):924-30. PubMed ID: 10989193
[TBL] [Abstract][Full Text] [Related]
26. Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro.
Minorics R; Szekeres T; Krupitza G; Saiko P; Giessrigl B; Wölfling J; Frank E; Zupkó I
Steroids; 2011 Jan; 76(1-2):156-62. PubMed ID: 20974162
[TBL] [Abstract][Full Text] [Related]
27. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP
Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552
[TBL] [Abstract][Full Text] [Related]
28. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
Vilpo JA; Vilpo LM
Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
[TBL] [Abstract][Full Text] [Related]
29. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
[TBL] [Abstract][Full Text] [Related]
30. Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
Cappellacci L; Franchetti P; Vita P; Petrelli R; Lavecchia A; Jayaram HN; Saiko P; Graser G; Szekeres T; Grifantini M
J Med Chem; 2008 Jul; 51(14):4260-9. PubMed ID: 18588281
[TBL] [Abstract][Full Text] [Related]
31. Augmentation of 1-beta-D-arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugs.
Freund A; Boos J; Harkin S; Schultze-Mosgau M; Veerman G; Peters GJ; Gescher A
Eur J Cancer; 1998 May; 34(6):895-901. PubMed ID: 9797704
[TBL] [Abstract][Full Text] [Related]
32. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
Parker WB; Shaddix SC; Chang CH; White EL; Rose LM; Brockman RW; Shortnacy AT; Montgomery JA; Secrist JA; Bennett LL
Cancer Res; 1991 May; 51(9):2386-94. PubMed ID: 1707752
[TBL] [Abstract][Full Text] [Related]
33. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
34. Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction.
Lee SK; Zhang W; Sanderson BJ
J Agric Food Chem; 2008 Aug; 56(16):7572-7. PubMed ID: 18656932
[TBL] [Abstract][Full Text] [Related]
35. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.
Sareen D; van Ginkel PR; Takach JC; Mohiuddin A; Darjatmoko SR; Albert DM; Polans AS
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3708-16. PubMed ID: 16936077
[TBL] [Abstract][Full Text] [Related]
36. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine.
Xie KC; Plunkett W
Cancer Res; 1996 Jul; 56(13):3030-7. PubMed ID: 8674058
[TBL] [Abstract][Full Text] [Related]
37. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle.
Pozo-Guisado E; Alvarez-Barrientos A; Mulero-Navarro S; Santiago-Josefat B; Fernandez-Salguero PM
Biochem Pharmacol; 2002 Nov; 64(9):1375-86. PubMed ID: 12392819
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
39. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
[TBL] [Abstract][Full Text] [Related]
40. Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells.
Weckbecker G; Weckbecker A; Lien EJ; Cory JG
Cancer Res; 1987 Feb; 47(4):975-8. PubMed ID: 2433036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
